** charts before earnings **
** charts after earnings **
- Reports Q2 (Sep) earnings of $0.49 per share, $0.19 better thanthe Capital IQ Consensus of $0.30; revenues rose 9.7% year/year to $66.7 mln vs the $63.41 mln Capital IQ Consensus.
- New order sales increased 9%, to $11.6 million for the quarter ended September 30, 2017, compared to $10.7 million for the same quarter in the prior year.
- "The trend we have seen in the last two quarters continued with increases in both new order and reorder sales during the quarter, along with an accelerated increase to net income for the third consecutive quarter. This increase to net income can be attributed to increased revenue with a shift in sales to higher margin items in the flea, tick and heartworm categories. Also, an income tax benefit of approximately $807,000 related to stock-based compensation was recognized in the quarter ended September 30, 2017. Average order value increased to $85 for the quarter compared to $82 for the same quarter the prior year. For the remainder of fiscal 2018 we will continue to focus on increasing sales and improving our service levels."
No comments:
Post a Comment